Guidelines on the diagnosis and treatment for acute promyelocytic leukemia: Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associacao Medica Brasileira - 2013

Universidade Estadual de CampinasUniversidade de São PauloUniversidade Federal de São Paulo (UNIFESP)Universidade de BrasiliaUniversidade Federal do Rio Grande do SulUniversidade Federal de Minas GeraisUniversidade Federal de PernambucoUNIFESP, EPMSciEL

Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines

We report an increased incidence of high relapse risk features in 157 APL Brazilian patients. Out of 134 patients treated with ATRA and anthracyclines, only 91 (67.9%) achieved remission because 43 (32%) died during induction. the death rate during consolidation was 10.5%. Bleeding complications were the most frequent cause of failure (21.6%).Med Sch Riberao Preto, Dept Internal Med, Ribeirao Preto, BrazilHosp Amaral Carvalho, Bone Marrow Transplantat Unit, Jau, BrazilUniv Fed Minas Gerais, Hematol Serv, Belo Horizonte, MG, BrazilSanta Casa São Paulo, Hematol Serv, São Paulo, BrazilFundacao Pio XII Barretos, Barretos, BrazilClin Hematol Riberao Preto, Ribeirao Preto, BrazilUniversidade Federal de São Paulo, Dept Hematol & Hemotherapy, São Paulo, BrazilUniv Estadual Campinas, Hemoctr, Campinas, BrazilSt Jude Childrens Hosp, Internal Outreach Program, Memphis, TN USAUniversidade Federal de São Paulo, Dept Hematol & Hemotherapy, São Paulo, BrazilWeb of Scienc

Guidelines on the diagnosis and treatment for acute promyelocytic leukemia: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2013

sem informação3617189sem informaçã

Comparison Between RT-PCR and RQ-PCR for Minimal Residual Disease Detection in Acute Promyelocytic Leukemia: The International Consortium on Acute Promyelocytic Leukemia (IC-APL) Experience

Univ Sao Paulo, Ribeirao Preto Med Sch, BR-14049 Ribeirao Preto, BrazilUniv Brasilia, Sch Med, Brasilia, DF, BrazilHEMOPE, Recife, PE, BrazilUniv Fed Rio Grande do Sul, Porto Alegre, RS, BrazilUniv Fed Parana, Hosp Clin, BR-80060000 Curitiba, PR, BrazilUniv Estadual Campinas, Natl Inst Sci & Technol Blood, Hematol & Hemotherapy Ctr, Campinas, SP, BrazilUniv Fed Minas Gerais, Clin Hosp, Belo Horizonte, MG, BrazilUNIFESP EPM, Sect Hematol & Blood Transfus, Dept Clin & Expt Oncol, Sao Paulo, BrazilSanta Casa Med Sch, Sao Paulo, BrazilAlbert Einstein Coll Med, Bronx, NY 10467 USAErasmus MC, Dept Hematol, Rotterdam, NetherlandsSt Jude Childrens Hosp, Memphis, TN 38105 USAUniv Roma Tor Vergata, Rome, ItalyKings Coll London, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, EnglandUniv Hosp La Fe, Dept Hematol, Valencia, SpainUNIFESP EPM, Sect Hematol & Blood Transfus, Dept Clin & Expt Oncol, Sao Paulo, BrazilWeb of Scienc

Aberrant Expression of the MLL5, BAALC, ID1, and WT1 Genes Is Associated with Higher Induction Mortality and Poorer Overall Survival in Acute Promyelocytic Leukemia Patients Treated with ATRA and Anthracycline-Based Chemotherapy: An International Consortium On Acute Promyelocytic Leukemia Study

Univ Sao Paulo, Ctr Cell Based Therapy, BR-14049 Ribeirao Preto, BrazilDana Farber Canc Inst, Boston, MA 02115 USAHEMOPE, Recife, PE, BrazilUniv Fed Rio Grande do Sul, Porto Alegre, RS, BrazilUniv Fed Parana, BR-80060000 Curitiba, Parana, BrazilUniv Estadual Campinas, Hematol & Hemotherapy Ctr, Natl Inst Sci & Technol Blood, Campinas, SP, BrazilUniv Fed Minas Gerais, Clin Hosp, Belo Horizonte, MG, BrazilUNIFESP EPM, Sect Hematol & Blood Transfus, Dept Clin & Expt Oncol, Sao Paulo, BrazilSanta Casa Med Sch, Sao Paulo, BrazilNorthwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USAAlbert Einstein Coll Med, Bronx, NY 10467 USAUniv Freiburg, Div Pediat Hematol & Oncol, Dept Pediat & Adolescent Med, D-79106 Freiburg, GermanyStanford Univ, Dept Med Hematol, Sch Med, Stanford, CA 94305 USAMem Sloan Kettering Canc Ctr, New York, NY 10021 USAKings Coll London, Dept Med & Mol Genet, Sch Med, London WC2R 2LS, EnglandHannover Med Sch, Hannover, GermanyBrigham & Womens Hosp, Boston, MA 02115 USASt Jude Childrens Res Hosp, Memphis, TN 38105 USAUniv Roma Tor Vergata, Rome, ItalyErasmus MC, Dept Hematol, Rotterdam, NetherlandsHosp Univ La Fe, Dept Clin Hematol, Valencia, SpainMed Sch Ribeirao Preto, Ribeirao Preto, BrazilUNIFESP EPM, Sect Hematol & Blood Transfus, Dept Clin & Expt Oncol, Sao Paulo, BrazilWeb of Scienc

Aberrant Expression of the MLL5, BAALC, ID1, and WT1 Genes Is Associated with Higher Induction Mortality and Poorer Overall Survival in Acute Promyelocytic Leukemia Patients Treated with ATRA and Anthracycline-Based Chemotherapy: An International Consortium On Acute Promyelocytic Leukemia Study

54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)1202